Crosswood SA
PAR:CROS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.3), the stock would be worth €10.16 (4% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.3 | €10.6 |
0%
|
| 3-Year Average | 1.3 | €10.16 |
-4%
|
| 5-Year Average | 1 | €8.27 |
-22%
|
| Industry Average | 1 | €8.07 |
-24%
|
| Country Average | 1.5 | €11.78 |
+11%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| FR |
|
Crosswood SA
PAR:CROS
|
112.7m EUR | 1.3 | 24.6 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
308.8B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 1 319.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
101.6B ZAR | 1.1 | 10.5 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.1B USD | 1 961.7 | 38 458.7 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
55.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
38.1B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
32.4B EUR | 7.8 | 174.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.8B USD | 53.9 | -3 291.8 | |
| US |
Q
|
Qnity Electronics Inc
NYSE:Q
|
30.3B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.5 |
| 70th Percentile | 2.6 |
| Max | 185.9 |
Other Multiples
Crosswood SA
Glance View
Crosswood SA engages in development and management of real estate assets. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2013-04-23. The Company’s main assets are offices, commercial buildings and houses. The firm operates through its subsidiaries, including SAS Hailaust & Gutzeit (100%), SCI Val Sans Retour (100%), SCI Villiers Luats (99.9%), SCI MP Maeva (100%), SNC DG Immo (100%), SNC Foch Le Sueur (100%) and SCI Dieu Vendome (87%). Crosswood SA has also a 30.76% direct interest in SA Societe Centrale Des Bois & Scieries de La Manche. The firm's properties are located in Bordeaux, Dijon, Lyon and Nancy, Nice, Reims and Toulouse, among others. As of December 31, 2011, the Company was 51.2%-owned by CFB and 43.51%-owned by Fonciere Vindi. In August 2013, it sold the Montivilliers site.
